Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04586959 · ClinicalTrials.gov registry record · NA

Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer

A NA study of Endometrial Cancer, sponsored by Anthony Costales, MD.

Recruiting
Registry status
NA
Development phase
278
Enrollment target
5
Study locations

NCT04586959 is a NA study of Endometrial Cancer that is actively recruiting participants, run by Anthony Costales, MD. The registered enrollment target is 278 participants, below the 522-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (47% lower). The trial reports 5 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04586959, a NA study of Endometrial Cancer, is actively recruiting participants, sponsored by Anthony Costales, MD.

RECRUITING
Registry status
NA
Development phase
278 participants
Enrollment target
5
Study locations

Study Summary

This is a prospective, multi-center, randomized non-inferiority phase III study to evaluate if patients undergoing a minimally invasive surgery for early stage uterine cancer have cancer cells in the fluid that is obtained at the time of their surgery when a uterine manipulator is placed versus patients who do not have a uterine manipulator placed.

Conditions Studied

Interventions

  • DEVICE Surgery with UM
  • DEVICE Surgery without UM

Study Locations (5)

Texas

  • Baylor College of Medicine- McNair Campus - Houston
  • Baylor College of Medicine - Houston
  • Ben Taub General Hospital - Houston
  • Harris Health System - Smith Clinic - Houston

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 278 participants
Start Date 2021-05-21
Est. Completion 2027-10
Phase NA

Sponsor

Anthony Costales, MD

1 total trials

What the Registry Record Tells You About NCT04586959

The ClinicalTrials.gov registry entry for NCT04586959 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 278 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 522-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (47% lower). The listed sponsor is Anthony Costales, MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Endometrial Cancer appearing as the primary indexed condition, and to 2 interventions - of which Surgery with UM is the first listed.

NCT04586959 reports 5 study locations spanning 2 distinct geographic areas - top geographies include Texas, Ohio.

Frequently Asked Questions

What is clinical trial NCT04586959 about?

NCT04586959 is a clinical study titled "Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer". This is a prospective, multi-center, randomized non-inferiority phase III study to evaluate if patients undergoing a minimally invasive surgery for early stage uterine cancer have cancer cells in the fluid that is obtained at the time of their surgery when a uterine manipulator is placed versus pati...

What is the current status of trial NCT04586959?

This trial is currently recruiting. It is a NA study. The enrollment target is 278 participants. The study started on 2021-05-21. Estimated completion is 2027-10.

What conditions does trial NCT04586959 study?

This clinical trial studies the following conditions: Endometrial Cancer.

What interventions are being tested in trial NCT04586959?

The interventions under investigation include: Surgery with UM (DEVICE), Surgery without UM (DEVICE).

Who is sponsoring clinical trial NCT04586959?

This trial is sponsored by Anthony Costales, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04586959 being conducted?

This trial has 5 study locations across Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endometrial Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.